Clinical Genomics Colvera

Clinical Genomics has launched Colvera, a blood-based test for colorectal cancer recurrence monitoring. The test measures methylation in circulating tumor DNA and can indicate the presence or absence of two altered genes associated with colorectal cancer. Colvera only requires a peripheral blood sample and can be administered alongside other colorectal cancer surveillance tests, the company said.